Get the latest market trends in your inbox

Stay on top of the latest market trends and economic insights with the Axios Markets newsletter. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Denver news in your inbox

Catch up on the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Des Moines news in your inbox

Catch up on the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Minneapolis-St. Paul news in your inbox

Catch up on the most important stories affecting your hometown with Axios Minneapolis-St. Paul

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tampa-St. Petersburg news in your inbox

Catch up on the most important stories affecting your hometown with Axios Tampa-St. Petersburg

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Trump visits troops in Afghanistan. Photo: Olivier Douliery/AFP via Getty Images

Joe Biden leads President Trump by a 41%-37% margin among active-duty troops, according to a Military Times poll published Monday.

Flashback: In a similar poll conducted shortly before the 2016 election, Trump led Hillary Clinton by a 41%-21% margin. Since 2016, though, the president's approval rating among active-duty troops has fallen from 46% to 38%, while his disapproval rating has climbed to 50%.

Editor's note: This story has been updated to reflect a correction from Military Times. Due to an error, their article initially showed Biden with 43.1%, but has been updated to 41.3%.

Go deeper

Scoop: Divisive Pentagon hire may rush troop withdrawals before Trump's exit

President Trump. Photo: Jim Watson / Getty Images

President Trump's newly installed acting Pentagon chief is bringing on a senior adviser in a sign the administration wants to accelerate the withdrawal of U.S. troops from the Middle East before the end of his presidency in January, three people familiar with the move told Axios.

Why it matters: A senior administration official says a wave of firings at the Pentagon and the hiring of Ret. Army Col. Douglas Macgregor is in part a settling of Trump's personal scores — but senior White House officials also have made clear "they want them more publicly to talk about getting out of Afghanistan by the end of the year."

USAID chief tests positive for coronavirus

An Air Force cargo jet delivers USAID supplies to Russia earlier this year. Photo: Mikhail Metzel/TASS via Getty Images

The acting administrator of the United States Agency for International Development informed senior staff Wednesday he has tested positive for coronavirus, two sources familiar with the call tell Axios.

Why it matters: John Barsa, who staffers say rarely wears a mask in their office, is the latest in a series of senior administration officials to contract the virus. His positive diagnosis comes amid broader turmoil at the agency following the election.

Bryan Walsh, author of Future
3 hours ago - Health

COVID-19 shows a bright future for vaccines

Illustration: Annelise Capossela/Axios

Promising results from COVID-19 vaccine trials offer hope not just that the pandemic could be ended sooner than expected, but that medicine itself may have a powerful new weapon.

Why it matters: Vaccines are, in the words of one expert, "the single most life-saving innovation ever," but progress had slowed in recent years. New gene-based technology that sped the arrival of the COVID vaccine will boost the overall field, and could even extend to mass killers like cancer.